Slingsby Brian Taylor — SEC insider filings
SEC reporting owner CIK 1963901. 11 insider filings on record with FilingPulse; latest filed 2026-09-24.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2023-02-13 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 509,259 shares, $7,499,996 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 1,654,320 shares, $53,532,803 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 1,000,000 shares @ $43.35 ($43,350,000) in Mineralys Therapeutics, Inc., filed 2025-11-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | Director | 11 | 2 legs · 509,259 sh · $7,499,996 | 3 legs · 1,654,320 sh · $53,532,803 | 18 |
Insider filings — Slingsby Brian Taylor
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-24 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Sale (S): 104,320 @ $28.81 | EDGAR |
| 2026-02-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) | Grant/award (A): 6,200 @ $0 · Other (J): 6,200 @ $0 · Other (J): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0 · Other (J): 8,300 (derivative) @ $0 · Other (J): 8,300 (derivative) @ $0 | EDGAR |
| 2025-11-21 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Sale (S): 1,000,000 @ $43.35 | EDGAR |
| 2025-04-25 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Purchase (P): 259,259 @ $13.50 | EDGAR |
| 2025-02-24 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Grant/award (A): 32,900 (derivative) @ $0 · Other (J): 32,900 (derivative) @ $0 · Other (J): 32,900 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Other (J): 22,000 (derivative) @ $0 · Other (J): 22,000 (derivative) @ $0 | EDGAR |
| 2024-07-26 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Sale (S): 550,000 @ $13.05 | EDGAR |
| 2024-05-23 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2023-07-14 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Other (J): 44,000 (derivative) @ $0 · Other (J): 88,000 (derivative) @ $0 | EDGAR |
| 2023-02-16 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Conversion (C): 4,314,093 · Purchase (P): 250,000 @ $16 · Conversion (C): 2,171,342 (derivative) @ $0 · Conversion (C): 2,142,751 (derivative) @ $0 | EDGAR |
| 2023-02-13 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with Catalys Pacific Fund, LP | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1963901 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs